Bain Capital Life Sciences Investors, LLC - DICERNA PHARMACEUTICALS INC ownership

DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 177 filers reported holding DICERNA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 3.06 and the average weighting 0.2%.

Quarter-by-quarter ownership
Bain Capital Life Sciences Investors, LLC ownership history of DICERNA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$62,098,000
-46.0%
3,080,2370.0%3.85%
-48.9%
Q2 2021$114,954,000
+46.0%
3,080,2370.0%7.53%
+68.8%
Q1 2021$78,762,000
+16.1%
3,080,2370.0%4.46%
+4.7%
Q4 2020$67,858,000
-7.6%
3,080,237
-24.5%
4.26%
-37.7%
Q3 2020$73,403,000
-29.2%
4,080,2370.0%6.84%
-37.0%
Q2 2020$103,638,000
+38.3%
4,080,2370.0%10.86%
-14.4%
Q1 2020$74,954,000
-16.6%
4,080,2370.0%12.68%
-5.4%
Q4 2019$89,888,000
-14.6%
4,080,237
-44.3%
13.40%
-50.5%
Q3 2019$105,262,000
-8.8%
7,330,2370.0%27.10%
-53.8%
Q2 2019$115,451,000
-11.8%
7,330,237
-17.9%
58.64%
+12.1%
Q1 2019$130,828,000
+37.0%
8,930,2370.0%52.31%
+60.3%
Q4 2018$95,464,000
-29.9%
8,930,2370.0%32.62%
+5.5%
Q3 2018$136,275,000
+24.6%
8,930,2370.0%30.93%
-9.8%
Q2 2018$109,395,000
+28.1%
8,930,2370.0%34.28%
-31.9%
Q1 2018$85,373,000
+5.9%
8,930,2370.0%50.34%
-4.9%
Q4 2017$80,640,0008,930,23752.91%
Other shareholders
DICERNA PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 1,355,392$29,859,0006.21%
Bain Capital Life Sciences Investors, LLC 3,080,237$67,858,0004.26%
DAFNA Capital Management LLC 587,756$12,948,0003.85%
SILVERARC CAPITAL MANAGEMENT, LLC 227,388$5,009,0002.91%
RTW INVESTMENTS, LP 7,253,857$159,802,0002.68%
Parkman Healthcare Partners LLC 331,513$7,303,0001.87%
Evolutionary Tree Capital Management, LLC 60,864$1,341,0001.02%
Eagle Health Investments LP 69,000$1,520,0000.97%
Woodline Partners LP 1,358,796$29,934,0000.79%
Affinity Asset Advisors, LLC 40,000$881,0000.47%
View complete list of DICERNA PHARMACEUTICALS INC shareholders